Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study finds a mouse model for episodic neurological disorders

05.08.2002


For years, physicians have noticed surprising similarities in the factors that seem to trigger attacks in such episodic neurological disorders as migraine and dyskinesia. Common triggers include psychological stress, caffeine or alcohol ingestion, fatigue, hormonal fluctuations and exercise.

A new study shows that a mouse model can be used to investigate how these substances and environmental factors trigger symptomatic attacks. The researchers also identified two drugs that can prevent attacks of such disorders in mice.

The study is the first to use mice to investigate triggers of episodic attacks, which are much more difficult to study in humans. Though the symptoms of episodic disorders vary, the fact that many of them share the same trigger factors may suggest a common disease mechanism.



"We finally have a model we can use to find out how these triggers destabilize nervous system function," says senior author Ellen Hess, Ph.D., of the Department of Neurology at Johns Hopkins Hospital, where the study was conducted. It was funded in part by the National Institute of Neurological Disorders and Stroke (NINDS) and appears in the August, 2002, issue of Pharmacology, Biochemistry and Behavior.

Dr. Hess and her colleagues studied a strain of mice with a gene mutation that causes them to have attacks of dyskinesia, or abnormal movements several times a day. The mutation affects calcium ion channels – tiny "gates" in cell membranes that control movement of electrically charged calcium ions into and out of cells. The movement disorder caused by this mutation is known as tottering syndrome in mice. The symptoms in tottering mice are similar to those of an episodic movement disorder in humans known as paroxysmal dyskinesia.

The researchers exposed the tottering mice to the most common triggers of human episodic disorders – stress, caffeine, and ethanol – and found that all three of these factors generated attacks in the mice. This shows that the tottering mice can be used to study how environmental factors cause episodic symptoms. The researchers also tested two drugs that block calcium ions from entering cells and found that these drugs could prevent tottering attacks in the mice. The first drug, nimodipine, blocked caffeine- and ethanol-induced attacks in the mice, while the second drug, MK801, blocked caffeine- and stress-triggered attacks.

"We can use the mouse model to understand how triggers work in single gene disorders, which are fairly rare, and then apply the information to more prevalent episodic disorders, like common migraine," says lead author Brandy Fureman, Ph.D., of the NINDS. The term common migraine refers to migraines that are not preceded by other neurological symptoms (auras). These headaches affect an estimated 20 to 24 million people in the United States. Other episodic neurological disorders include periodic paralysis, hemiplegic migraine, and episodic ataxia.

"The study opens up a whole new way to look at triggers of attacks. Stress, caffeine and alcohol are factors we’ve all known about for years, but we still haven’t figured out why they can cause certain symptoms in certain people," says Dr. Fureman. Now, researchers will be able to control the onset of attacks in studies of mice to learn how trigger factors cause a shift from normal brain function to the abnormal activity that causes symptoms.

Because common migraine and other episodic neurological disorders have the same triggers as the tottering syndrome in mice, the researchers hope that their findings will improve understanding of these disorders and lead to effective treatments for humans.

One of the drugs tested, nimodipine, is commonly used in humans to treat cardiac problems like hypertension. "We are finding a new use for an old drug," Dr. Fureman says. "Drugs that have already gone through the FDA’s rigorous safety testing, like nimodipine, are easier to move into clinical trials once the basic research progresses to that point."

"The next step is to start testing drugs that we think can interfere with those three triggers to stop the neurological dysfunction in humans," says Dr. Hess. She and her colleagues are now using the tottering mice to test compounds that are currently used by humans for other disorders.

The NINDS is a component of the National Institutes of Health in Bethesda, Maryland, and is the nation’s primary supporter of biomedical research on the brain and nervous system.


Fureman BE, Jinnah HA, Hess EJ. "Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering." Pharmacology, Biochemistry and Behavior, Vol. 73, No. 2, August 2002.


Tania Zeigler | EurekAlert!
Further information:
http://www.ninds.nih.gov/

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>